Document Detail

The future of glioma treatment: stem cells, nanotechnology and personalized medicine.
MedLine Citation:
PMID:  23030489     Owner:  NLM     Status:  In-Data-Review    
The development of novel therapies, imaging techniques and insights into the processes that drive growth of CNS tumors have allowed growing enthusiasm for the treatment of CNS malignancies. Despite this energized effort to investigate and treat brain cancer, clinical outcomes for most patients continue to be dismal. Recognition of diverse tumor subtypes, behaviors and outcomes has led to an interest in personalized medicine for the treatment of brain tumors. This new paradigm requires evaluation of the tumor phenotype at the time of diagnosis so that therapy can be specifically tailored to each individual patient. Investigating novel therapies involving stem cells, nanotechnology and molecular medicine will allow diversity of therapeutic options for patients with brain cancer. These exciting new therapeutic strategies for brain tumors are reviewed in this article.
Maryam Rahman; Brian Hoh; Nathan Kohler; Erin M Dunbar; Gregory Ja Murad
Related Documents :
21700219 - Acetylation targets the m2 isoform of pyruvate kinase for degradation through chaperone...
12802789 - The interaction of thymidylate synthase expression with p53-regulated signaling pathway...
21597289 - Beyond antiangiogenesis: intratumorally injected bevacizumab plays a cisplatin-sensitiz...
21193839 - A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and ste...
24781949 - Downregulation of abcg2 protein inhibits migration and invasion in u251 glioma stem cells.
25064729 - Cancer stem cell detection and isolation.
11673179 - Carcinoid tumor development in an intramedullary spinal cord mature teratoma.
12897659 - F-18 fdg pet imaging in gastrointestinal stromal tumor.
16449819 - Secretagogin is a novel marker for neuroendocrine differentiation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Future oncology (London, England)     Volume:  8     ISSN:  1744-8301     ISO Abbreviation:  Future Oncol     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-10-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101256629     Medline TA:  Future Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1149-56     Citation Subset:  IM    
Department of Neurosurgery, University of Florida, Box 100265, Gainesville, FL 32610, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The changing landscape of therapeutic strategies for recurrent ovarian cancer.
Next Document:  Detection of smell print differences between nonmalignant and malignant prostate cells with an elect...